CPT® Code 0567T

Deleted

Permanent fallopian tube occlusion with degradable biopolymer implant, transcervical approach, including transvaginal ultrasound

The procedure described by CPT® Code 0567T involves the permanent occlusion of the fallopian tubes in female patients, utilizing a degradable biopolymer implant. This method is performed through a transcervical approach, which means that the procedure is conducted via the cervix, allowing for direct access to the uterine cavity. The primary goal of this procedure is sterilization, achieved by blocking the fallopian tubes to prevent the passage of eggs from the ovaries to the uterus. The biopolymer implant is designed to trigger a natural wound-healing response in the body, leading to the formation of scar tissue that permanently occludes the fallopian tubes. To initiate the procedure, a transvaginal ultrasound is performed using a vaginal probe, which provides visualization of the uterus and the fallopian tubes' location. This imaging is crucial for accurately placing the occlusion devices. Following the ultrasound, a flexible catheter is introduced through the cervix into the uterine cavity, allowing for the precise delivery of the biopolymer into the fallopian tubes. The biopolymer is injected in a liquid form, and as it degrades over time, it facilitates the bonding of the fallopian tissue, ultimately leading to closure. A follow-up ultrasound is typically conducted three months post-procedure to confirm the successful occlusion of the fallopian tubes, ensuring the effectiveness of the sterilization process.